Shelburne, VT, United States of America

Sean Diehl

This inventor holds 1 USPTO granted patent. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sean Diehl. Retrieved from https://idiyas.com/inventor/sean-diehl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sean Diehl: Innovator in Zika Neutralization

Introduction

Sean Diehl is an accomplished inventor based in Shelburne, Vermont. He has made significant contributions to the field of immunology, particularly in the development of neutralizing antibodies for the Zika virus. His work is crucial in the ongoing fight against viral infections that pose a threat to public health.

Latest Patents

Sean Diehl holds a patent for "Highly Specific Zika Neutralizing Human Antibodies." This innovative patent represents a significant advancement in the development of therapeutic options for Zika virus infections. The patent showcases his expertise and dedication to addressing critical health challenges.

Career Highlights

Diehl is affiliated with the University of North Carolina at Chapel Hill, where he conducts research and collaborates with other experts in the field. His work at the university has allowed him to explore various aspects of immunology and contribute to groundbreaking research.

Collaborations

Throughout his career, Sean Diehl has collaborated with notable colleagues, including Huy Tu and Aravinda De Silva. These partnerships have enhanced his research efforts and facilitated the sharing of knowledge and expertise in the field of viral immunology.

Conclusion

Sean Diehl's contributions to the development of Zika neutralizing antibodies highlight his commitment to advancing medical science. His innovative work continues to pave the way for new therapeutic strategies in combating viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…